Dr Murat Ayhan
- 専門分野: Clinical oncologist
- 36年の経験
- 話します:English
- 勤務先: トルコ, イスタンブール, Liv Hospital Vadistanbul
Dr. Murat Ayhan is an associate professor of medical oncology at Liv Hospital Vadistanbul in Istanbul. He specializes in the treatment of breast, lung, and colorectal cancers. Dr. Ayhan is a prolific researcher with over 30 published scientific articles. He focuses on molecular oncology and targeted drug therapies for metastatic conditions.
- Participates in international clinical trials for novel breast and lung cancer treatments.
- Authored several medical book chapters on targeted agents and oncological emergencies.
- Expert in utilizing FDG PET/CT imaging to predict treatment responses in breast cancer.
- Works at a JCI-accredited hospital recognized for colorectal surgery excellence.
患者様レビュー
医師のサービス
調子はいかがですか？
資格
Specialization & Oncology Approach
Dr. Ayhan treats advanced treatment protocols for a wide range of solid tumors. His primary areas of interest include breast and lung cancer, and colorectal and gastrointestinal cancers. He also treats gynecological and urogenital cancers and provides molecular oncology through targeted therapies.
He uses molecular diagnostics to identify specific gene aberrations, such as Pik3ca mutations. This data helps him select targeted agents like tyrosine kinase inhibitors. He also treats bone cancer and liver malignancies because these conditions often require specialized oncological management.
Clinical Research & Trial Experience
Dr. Ayhan is a researcher for several multicenter international studies. He evaluates the efficacy of new endocrine therapies and subcutaneous immunotherapies. His research work includes evaluating GDC-9545 and GDC-0077 for hormone receptor-positive breast cancer.
Furthermore, he compares subcutaneous versus intravenous atezolizumab for lung cancer. He also investigates apalutamide for high-risk hormone-sensitive prostate cancer. Additionally, he studies biomarker identification for patients with advanced stage urothelial cancer and fibroblast growth factor receptor gene aberrations.
Academic & Professional Experience
Dr. Ayhan has practiced at several major Turkish medical institutions. He achieved the rank of Associate Professor in 2023. His previous roles include:
- Liv Hospital Ulus
- Adıyaman University Training and Research Hospital
- Istanbul Umraniye Training and Research Hospital
Education & Training
- 2001 – Kızıltepe Anatolian High School
- 2007 – Dicle University Faculty of Medicine – Medical Degree
- 2014 – Istanbul Medeniyet University Göztepe Training and Research Hospital – Residency
- 2021 – Kartal City Hospital – Specialist Training
- 2023 – Associate Professorship in Medical Oncology
Scientific Publications & Books
Dr. Ayhan has authored over 30 peer-reviewed articles in journals such as Future Oncology and Journal of Chemotherapy. He has written chapters for the Physicians' Chemotherapy Cancer Drug Manual. Additionally, he contributed to books on internal medicine emergencies and gastrointestinal stromal tumors.
His notable publications include:
- "Value of FDG PET/CT in Predicting Pathologic Complete Response After Neoadjuvant Chemotherapy"
- "Real-world data on efficacy and safety of first-line alectinib treatment"
- "Drug interactions and side effects of targeted agents" (Book Chapter)
- "Survival analysis of patients with triple-negative breast cancer"
- "Prognostic significance of mucinous histology in left sided metastatic colorectal cancers"
- "Factors affecting the mortality rate of patients with cancer hospitalized with COVID-19"
こちらもご興味をお持ちいただけるかもしれません
支払い・特典
当社サービスへのお支払いはありません
クリニックで直接またはその公式銀行口座にお支払いいただきます。
一部のクリニックでは保証金が必要な場合があります。
分割払いオプションでお支払いを分散してください。
Bookimedにお友達を紹介して報酬を獲得してください。